Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol

Invasive meningococcal disease causes significant morbidity and mortality worldwide, with serogroup B being one of the predominant serogroups in Australia for many years. The South Australian (SA) State Government recently funded the introduction of a 4CMenB vaccination program for infants, children...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Helen S. Marshall, Prabha H. Andraweera, Bing Wang, Mark McMillan, Ann P. Koehler, Noel Lally, Sara Almond, Emma Denehy, Michele A’Houre, Lynne C. Giles, Louise Flood
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2021-05-01
coleção:	Human Vaccines & Immunotherapeutics
Assuntos:	vaccine 4cmenb meningitis meningococcal disease gonorrhoea
Acesso em linha:	http://dx.doi.org/10.1080/21645515.2020.1827614
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!